Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study.
Authors
Monaghan, Phillip JKyriacou, Angelos
Sturgeon, C
Davies, A
Trainer, Peter J
White, A
Higham, Claire E
Affiliation
The Christie Pathology Partnership Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, M20 4BX, UKIssue Date
2016-06-03
Metadata
Show full item recordAbstract
It is recognized that measurement of ACTH-precursor peptides including proopiomelanocortin (POMC) has clinical utility in identifying the aetiology of Cushing's syndrome. Recent data have also demonstrated cross-reactivity of POMC in ACTH immunoassays used in clinical laboratories. The aim of this study was to assess the cross-reactivity of POMC in the main commercial immunoassays for ACTH and to survey the awareness of laboratory professionals to this potential interference.Citation
Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study. 2016: Clin EndocrinolJournal
Clinical EndocrinologyDOI
10.1111/cen.13118PubMed ID
27256168Type
ArticleLanguage
enISSN
1365-2265ae974a485f413a2113503eed53cd6c53
10.1111/cen.13118
Scopus Count
Collections
Related articles
- Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
- Authors: Gibson S, Crosby SR, Stewart MF, Jennings AM, McCall E, White A
- Issue date: 1994 Apr
- Cushing syndrome in a child due to pro-opiomelanocortin (POMC) secretion from a yolk sac tumor.
- Authors: Gevers EF, Meredith S, Shah P, Torpiano J, Peters C, Sebire NJ, Slater O, White A, Dattani MT
- Issue date: 2017 Feb
- Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
- Authors: Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H
- Issue date: 1993 Dec
- Predicting the development of Cushing's syndrome in medullary thyroid cancer: utility of proopiomelanocortin messenger ribonucleic acid in situ hybridization.
- Authors: Sheikh-Ali M, Krishna M, Lloyd R, Smallridge RC
- Issue date: 2007 Jul
- A new generation IRMA for ACTH with improved specificity: validation in various physiological and pathological conditions.
- Authors: Guiban D, Massias JF, Dugué MA, Coste J, Bertagna X, Raffin-Sanson ML
- Issue date: 2001 Apr